CE webinars

Post-cancer treatment infertility is an iatrogenic risk for some cancer patients. Often, there exists a limited window of opportunity for informed decision making regarding fertility and fertility preservation. The emerging field of oncofertility can help guide patients as they navigate their fertility preservation options prior to cancer treatment and infertility treatment options in survivorship.

This program outlines the key parameters in nutrition assessment for the development of patient-specific PN solutions. The components of PN solution, the guidelines for safe PN delivery, and each step in the writing of a PN formula are also discussed in detail.

Upon Completion of this CE Program, the audience will have and overview and background on Biosimilars. The program provide information on biosimilars and differentiate from small molecule drugs and generic products. The CE will provide and understanding of biosimilar interchangeability, approval criteria, impact on access to treatment, patient outcomes and potential challenges related to biosimilars.

This presentation will identify some of the common mental health issues experienced by patients with PAH and address both clinical and psychosocial influencers. There is such an interconnectedness between physical and mental health and exploring this dimension and designing interventions is opportune. Treating mental health is as important as treating physical health, and vice versa. Assessing mental health and implementing and evaluating appropriate interventions should be part of every treatment plan.This presentation will identify some of the common mental health issues experienced by patients with PAH and address both clinical and psychosocial influencers. There is such an interconnectedness between physical and mental health and exploring this dimension and designing interventions is opportune. Treating mental health is as important as treating physical health, and vice versa. Assessing mental health and implementing and evaluating appropriate interventions should be part of every treatment plan.

This program details information about PN solutions, ambulatory pumps, the assessment of patients with nutritional disorders, and managing complications for patients receiving PN in the home. 

Upon completion of this CE program, the audience will have a better understanding of the Duchenne Muscular Dystrophy therapy along with the ability to identify the various treatment methods for this condition. The CE provides valuable information on the overall treatment groups, the specific agents within each group, and how they work to achieve a similar end goal.